Catalyst Pharmaceutical (CPRX) Stock Moves -0.12%: What You Should Know

Catalyst Pharmaceuticals Stock Gets Relative Strength Rating Lift

How to Spot Stock Catalysts — With Key Patterns and Examples

On day one of our Catalyst Advocacy Scholars Summit (CASS), 12 scholars from the University of Notre Dame immersed themselves in learning about rare diseases, the important outreach our company does in the therapeutic areas of #DMD (Duchenne muscular dystrophy) and #LEMS (Lambert-Eaton myasthenic syndrome), the communities we serve, and so much more. They arrived with curiosity, asked thought-provoking questions, and demonstrated a true passion for understanding how we can better support patient

Catalyst | Definition, Types & Function

CATALYST: A Novel Approach to Treating Diabetes

Catalyst Pharmaceuticals (CPRX) Reports Record Q4 and Full Year 2025 Results

Catalyst Pharmaceuticals: Proven Recipe For Profitability, Lacks Sufficient Upside Potential | Seeking Alpha Investing Groups

Tech Leader Rockets After Striking A Key Deal With Teva